Chronic hyperinsulinemia inhibits platelet-activating factor (PAF) biosynthesis in the rat kidney

Journal of Lipid Mediators and Cell Signalling

Volumn 16, Issue 1, 1997, Pages 23-37

  Kudolo, George B ^a   Koopmans, Sietse J ^b   Haywood, Joseph R ^c   DeFronzo, Ralph A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c University of Texas Health Science Center   (United States)

Author keywords

hyperinsulinemia; insulin resistance; kidney; platelet activating factor

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; ACYLTRANSFERASE; GLUCOSE; INSULIN; PROSTAGLANDIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTERIAL PRESSURE; ARTICLE; BIOSYNTHESIS; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CATABOLISM; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ACETYLTRANSFERASES; ANIMALS; BLOOD PRESSURE; CHRONIC DISEASE; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; KIDNEY; MALE; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031149561     PISSN: 09297855     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-7855(96)00565-2     Document Type: Article

References (31)

1. Blank, M.L., Lee, J., Cress, E.A. and Snyder, F. (1988) Stimulation of the de novo pathway for the biosynthesis of platelet-activating factor (PAF) via cytidylyltransferase activation in cells with minimal endogenous PAF production. J. Biol. Chem. 263, 5656-5661.
2. Blank, M.L., Smith. Z.L., Cress, E.A. and Snyder, F. (1990) Characterization of the enzymatic hydrolysis of acetate from alkylacetylglycerols in the de novo pathway of PAF biosynthesis. Biochim. Biophys. Acta 1042, 153-158.
3. Bligh, E.G. and Dyer, W.J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.
4. DeFronzo, R.A. and Ferrannini, E. (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14, 173-194.
5. DeFronzo, R.A., Tobin, J.D. and Andres R. (1979) Glucose clamp techniques method for quantifying insulin secretion and resistance. Am. J. Physiol 237, E214-E223.
6. Gulli, G., Ferrannini, E., Stern, M., Haffner, S. and DeFronzo, R.A. (1992) The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of 2 Mexican-American NIDDM parents. Diabetes 41, 1575-1586.
7. Haffner, S.M., Stern, M.P., Hazuda, H.P., Mitchell B.D. and Patterson, J.K. (1990) Cardiovascular risk factors in confirmed prediabetics: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263, 2893-2898.
8. Haffner, S.M., Valdez, R.A., Hazuda, H.P., Mitchell, B.D., Morales, P.A. and Stern, M.P. (1992) prospective analysis of the insulin resistance syndrome (Syndrome x). Diabetes 41, 715-722.
9. Kramer, R.M., Patton, G.M., Pritzker, C.R. and Deykin, D. (1984) Metabolism of platelet-activating factor in human platelets. Transacylase-mediated synthesis of 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. J. Biol. Chem. 259, 13316-13320.
10. Koopmans, S.J., Banduch, D.L. and DeFronzo, R.A. (1993) Effect of chronic hyperinsulinemic euglycemia on glucose metabolism in conscious normal rats. Diabetologia 36 (Suppl 1), No. 471, pp. A123.
11. Koopmans, S.J., DeBoer, S.F., Sips, H.C.M., Radder, J.K., Frolich, M. and Krams, H.M.J. (1991) Whole body and hepatic insulin action in normal, starved, and diabetic rats. Am. J. Physiol. 260, E825-E832.
12. Kudolo, G.B. and Harper, M.J.K. (1989) Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits. Biol. Reprod. 41, 587-603.
13. Kudolo, G.B., and Harper, M.J.K. (1995) Lyso-PAF:acetyl-CoA acetyltransferase and CDP-choline cholinephosphotransferase activities in the rabbit endometrium. J. Lipid Mediators 11, 145-158.
14. Kudolo, G.B., Yang, Y.Q., Chen, D-B., Jones, M.A. and Harper, M.J.K. (1995) Differential metabolism of exogenous platelet-activating factor by glandular epithelial cells of rabbit endometrium. J. Reprod. Fertil. 105, 315-324.
15. Lai, F.M., Shepherd, C.A., Cervoni, P. and Wissner, A (1983) Hypotensive and vasodilatory activity of 1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine in the normotensive rat. Life Sci. 32, 1159-1166.
16. Lee, T-c., Malone, B. and Snyder, F. (1986) A new de novo pathway for the formation of 1-alkyl-2-acetyl-sn-glycerols, precursors of platelet activating factor. Biochemical characterization of 1-alkyl-2-lyso-sn-glycero-3-P:acetyl CoA acetyltransferase in rat spleen. J. Biol. Chem. 261, 5373-5377.
17. Lee, T-c., Malone, B. and Snyder, F. (1988) Formation of 1-alkyl-2-acetyl-sn-glycerols via the de novo biosynthetic pathway for platelet-activating factor. Characterization of 1-alkyl-2-acetyl-sn-glycero-3-phosphate phosphohydrolase in rat spleens. J. Biol. Chem. 263, 1755-1760.
18. Martin, D.S., Segura, T. and Haywood, J.R. (1991) Cardiovascular responses to bicuccline in the paraventricular nucleus of the rat. Hypertension 18, 48-55.
19. 2 and plasma lyso-PAF in the undipped one-kidney hypertensive rat. Am. J. Physiol. 251 (Heart Circ. Physiol. 20), H1361-H1364.
20. McGowan, H.M., Vandongen, R., Kelly, L.D. and Hill, K.J. (1988) Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycerophosphocholine) in blood after reversal of renal clip hypertension in the rat. Clin. Sci. 74, 393-396.
21. Muirhead, E.E., Byer, L.W., Desiderio, D.M., Brooks, B. and Brosius, W.M. (1981) Antihypertensive lipids from the kidney: alkyl ether analogs of phosphatidylcholine. Fed. Proc. 40, 2285-2290.
22. Muirhead, E.E., Folkow, B., Byer, L.W. et al. (1983) Cardiovascular effects of antihypertensive polar and neutral renomedullary lipids. Hypertension 5 (Suppl. I), I-112-I-118.
23. Reaven, G.M. (1988) Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
24. Renooij, W. and Snyder, F. (1981) Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues. Biochim. Biophys. Acta 663, 545-556.
25. Robinson, M., Blank, M.L. and Snyder, F. (1985) Acylation of lysophospholipids by rabbit alveolar macrophages. Specificities of CoA-dependent and CoA-independent reactions. J. Biol. Chem. 260, 7889-7895.
26. Satoh, K., Imaizumi, T.-a., Kawamura, Y., Yoshida, H., Takamatsu, S. and Takamatsu, M. (1989). Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension. Prostaglandins 37, 673-682.
27. Snyder, F. (1990) Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am. J. Physiol. (Cell Physiol.) 259, C697-C708.
28. Sugiura, T., Fukuda, T., Masuzawa, Y. and Waku, K. (1990) Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leucocytes. Biochim. Biophys. Acta 1047, 223-232.
29. Stafforini, D.M., McIntyre T.M., Carter M.E. and Prescott S.M. (1987). Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J. Biol. Chem. 262, 4215-4222.
30. Uemura, T., Lee, T.-C. and Snyder, F. (1991). A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway. J. Biol. Chem. 266, 8266-8272.
31. Woodard, D.S., Lee, T-c., and Snyder, F. (1987) The final step in the de novo biosynthesis of platelet-activating factor. Properties of a unique CDP-choline:1-alkyl-2-acetyl-sn-glycerol cholinephosphotransferase in microsomes from the renal inner medulla of rats. J. Biol. Chem. 262, 2520-2527.